The global biologics safety testing market is expanding rapidly as pharmaceutical and biotechnology companies increase investments in vaccines, monoclonal antibodies, biosimilars, and cell & gene therapies. Regulatory agencies worldwide are also tightening safety and contamination control standards, creating strong demand for advanced biologics testing solutions.
The global biologics safety testing market is projected to grow from USD 5.57 billion in 2026 to USD 9.66 billion by 2031, at a CAGR of 11.6% during the forecast period. The market was valued at USD 4.97 billion in 2025. Biologics safety testing comprises analytical products and services used to detect microbial contamination, endotoxins, mycoplasma, viruses, and process-related impurities, ensuring the safety, quality, and regulatory compliance of biologic products. The market includes assays, kits and reagents, instruments, and specialized testing services that support biologics development, manufacturing, and batch release across monoclonal antibodies, vaccines, cell and gene therapies, blood products, and other biologics.
Why Biologics Safety Testing Matters
Biologics safety testing ensures that biologic drugs are free from contamination, endotoxins, mycoplasma, viruses, and other impurities before reaching patients. These tests are critical across:
- Vaccine development
- Cell & gene therapy manufacturing
- Biosimilar production
- Monoclonal antibody development
- Blood and plasma-derived therapies
As biopharma pipelines become more complex, companies are investing heavily in rapid microbiological methods, automation, AI-assisted testing, and outsourced laboratory services.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144
Top Companies in the Biologics Safety Testing Market
1. Thermo Fisher Scientific
Thermo Fisher Scientific is one of the most influential players in the biologics safety testing market. The company offers comprehensive sterility testing, endotoxin testing, mycoplasma detection, and viral safety solutions through advanced instruments, reagents, and consumables.
Key Strengths
- Rapid microbial detection systems
- Global laboratory infrastructure
- Strong biopharma manufacturing partnerships
- Advanced PCR-based sterility testing platforms
The company continues expanding its biologics testing portfolio to support large-scale biologics and mRNA manufacturing.
2. Charles River Laboratories
Charles River Laboratories is a major provider of outsourced biologics safety testing services. The company specializes in endotoxin testing, sterility assays, viral clearance studies, and microbial identification.
Key Strengths
- Strong CRO and CDMO support services
- Global biosafety testing laboratories
- Expertise in cell & gene therapy testing
- Rapid microbiological methods
Charles River is also investing in AI-driven and non-animal testing methodologies as regulatory frameworks evolve.
3. Merck KGaA (MilliporeSigma)
Merck KGaA is a leading supplier of biologics safety testing products and analytical solutions through its life science business.
Key Strengths
- Endotoxin and pyrogen testing
- Filtration technologies
- Viral safety testing solutions
- Bioprocessing expertise
The company has expanded its biosafety testing facilities to address growing global demand for biologics and advanced therapies.
4. Lonza
Lonza plays a significant role in biologics safety testing with integrated CDMO and biosafety testing capabilities.
Key Strengths
- Mycoplasma testing
- Endotoxin testing platforms
- Cell and gene therapy support
- Residual DNA analysis solutions
Lonza’s strong position in biologics manufacturing gives it a competitive advantage in integrated testing services.
5. Eurofins Scientific
Eurofins Scientific operates one of the largest global laboratory networks and provides extensive biologics safety testing services for pharmaceutical manufacturers.
Key Strengths
- Global testing infrastructure
- Regulatory compliance expertise
- Biopharmaceutical product testing
- Fast turnaround testing services
The company is particularly strong in outsourced biologics quality assurance services.
6. Sartorius AG
Sartorius AG is known for laboratory instruments, filtration technologies, and microbiological testing solutions.
Key Strengths
- Microsart testing systems
- Bioprocess analytics
- Laboratory automation
- Cell therapy support technologies
Sartorius benefits from increasing adoption of automated biologics manufacturing workflows.
7. SGS
SGS provides biosafety and analytical testing services for pharmaceutical and biotechnology companies worldwide.
Key Strengths
- Global laboratory network
- Biopharmaceutical quality testing
- GMP-compliant services
- Regulatory consulting support
The company continues expanding its biologics testing capabilities to support large-molecule drug development.
8. WuXi AppTec
WuXi AppTec is emerging as a strong player in biologics safety testing, particularly in the Asia-Pacific region.
Key Strengths
- Integrated R&D and testing services
- Biologics development support
- Viral safety testing
- Cell and gene therapy expertise
Its integrated CDMO model supports rapid biologics development and commercialization.
Emerging Trends Shaping Competition
The biologics safety testing market is evolving quickly with several major trends:
- AI-enabled biosafety analysis
- Rapid sterility and endotoxin testing
- Growth of cell & gene therapies
- Increased outsourcing to CROs and CDMOs
- Expansion of non-animal testing methodologies
- Automated microbiological testing platforms
Regulatory agencies are also encouraging modern testing alternatives that improve speed, accuracy, and cost efficiency.
Final Thoughts
The biologics safety testing market is becoming increasingly competitive as biologic drug pipelines continue expanding globally. Industry leaders such as Thermo Fisher Scientific, Charles River Laboratories, Merck KGaA, and Lonza are driving innovation through advanced testing technologies, automation, and integrated biosafety solutions.
As pharmaceutical companies prioritize regulatory compliance and faster biologics commercialization, demand for reliable safety testing partners is expected to rise significantly over the next decade.
Inquire Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=34624144